Variability in postheparin hepatic lipase activity is associated with plasma adiponectin levels in African Americans

Journal of Investigative Medicine

Volumn 55, Issue 4, 2007, Pages 187-194

  Clarenbach, Jacob J ^a   Vega, Gloria Lena ^a   Adams Huet, Beverley ^a   Considine, Robert V ^b   Ricks, Madia ^c   Sumner, Anne E ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Adiponectin; African Americans; Hepatic triglyceride lipase

Indexed keywords

ADIPONECTIN; LIVER TRIACYLGLYCEROL LIPASE;

ADULT; AFRICAN AMERICAN; ANTHROPOMETRY; ARTICLE; BODY MASS; DEMOGRAPHY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; MALE; NORMAL HUMAN; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 34848866918     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2007.07001     Document Type: Article

References (40)

1. Gartside PS, Khoury P, Glueck CJ. Determinants of high-density lipoprotein cholesterol in blacks and whites: the second National Health and Nutrition Examination Survey. Am Heart J 1984;108(3 Pt 2):641-53.
2. Tyroler HA, Glueck CJ, Christensen B, Kwiterovich PO Jr. Plasma high-density lipoprotein cholesterol comparisons in black and white populations. The Lipid Research Clinics Program Prevalence Study. Circulation 1980;62(4 Pt 2): IV99-107.
3. Grundy SM. Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. Clin Cornerstone 2006;8Suppl 1:S21-7.
4. Blades B, Vega GL, Grundy SM. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb 1993;13:1227-35.
5. Sumner AE, Vega GL, Genovese DJ, et al. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism 2005;54: 902-9.
6. Vega GL, Clark LT, Tang A, et al. Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 1998;39:228-32.
7. Kuusi T, Ehnholm C, Viikari J, et al. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res 1989;30:1117-26.
8. Zambon A, Austin MA, Brown BG, et al. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 1993;13:147-53.
9. Taskinen MR, Nikkila EA. Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Relation to high-density and very-low-density lipoproteins and response to treatment. Diabetologia 1979; 17:351-6.
10. Bersot TP, Vega GL, Grundy SM, et al. Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. J Lipid Res 1999;40:432-8.
11. Ehnholm C, Huttunen JK, Kinnunen PJ, et al. Effect of oxandrolone treatment on the activity of lipoprotein lipase, hepatic lipase and phospholipase A1 of human postheparin plasma. N Engl J Med 1975;292:1314-7.
12. Grundy SM, Vega GL, Otvos JD, et al. Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence. J Lipid Res 1999;40:229-34.
13. Vega GL, Gao J, Bersot TP, et al. The -514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity. J Lipid Res 1998;39:1520-4.
14. Nie L, Wang J, Clark LT, et al. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res 1998; 39:1127-30.
15. Eckel RH. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 1989;320:1060-8.
16. Havel RJ. Postprandial lipid metabolism: an overview. Proc Nutr Soc 1997;56:659-66.
17. Maheux P, Azhar S, Kern PA, et al. Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Diabetologia 1997;40: 850-8.
18. Sumner AE, Bergman RN, Vega GL, et al. The multiphasic profile of free fatty acids during the intravenous glucose tolerance test is unresponsive to exogenous insulin. Metabolism 2004;53:1202-7.
19. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
20. Osei K, Gaillard T, Schuster D. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes. Obes Res 2005;13:179-85.
21. Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126-33.
22. Ezenwaka CE, Kalloo R, Uhlig M, Eckel J. Relationship between adiponectin and metabolic variables in Caribbean offspring of patients with type 2 diabetes mellitus. Horm Metab Res 2004;36:238-42.
23. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
24. Inoue M, Maehata E, Yano M, et al. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism 2005;54:281-6.
25. Furler SM, Gan SK, Poynten AM, et al. Relationship of adiponectin with insulin sensitivity in humans, independent of lipid availability. Obesity (Silver Spring) 2006;14:228-34.
26. Altinova AE, Toruner F, Bukan N, et al. Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. Endocr J 2007;54:221-6.
27. Shaibi GQ, Cruz ML, Weigensberg MJ, et al. Adiponectin independently predicts metabolic syndrome in overweight Latino youth. J Clin Endocrinol Metab 2007;92:1809-13.
28. Wannamethee SG, Tchernova J, Whincup P, et al. Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters. Int J Obes (Lond) Jan 30 2007. Epub ahead of print.
29. Schneider JG, von Eynatten M, Schiekofer S, et al. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 2005;28:2181-6.
30. Saiki A, Oyama T, Endo K, et al. Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. Diabetes Res Clin Pract 2007;76:93-101.
31. Kim SM, Cho KH, Park HS. Relationship between plasma adiponectin levels and the metabolic syndrome among Korean people. Endocr J 2006;53:247-54.
32. Ferris WF, Naran NH, Crowther NJ, et al. The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res 2005;37:695-701.
33. Wajcberg E, Sriwijitkamol A, Musi N, et al. Relationship between vascular reactivity and lipids in Mexican Americans with type 2 diabetes treated with pioglitazone. J Clin Endocrinol Metab 2007;92:1256-62.
34. Lee JK, Chu CH, Chuang MJ, et al. Two-year effect of rosiglitazone in Chinese poorly controlled type 2 diabetic patients. Chang Gung Med J 2006;29:486-92.
35. Al Majali K, Cooper MB, Staels B, et al. The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients. Diabetologia 2006;49:527-37.
36. Choi KM, Ryu OH, Lee KW, et al. Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract 2007;75:235-40.
37. Hashimoto N, Kanda J, Nakamura T, et al. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism 2006;55:1653-7.
38. Jaleel F, Jaleel A, Aftab J, Rahman MA. Relationship between adiponectin, glycemic control and blood lipids in diabetic type 2 postmenopausal women with and without complication of ischemic heart disease. Clin Chim Acta 2006;370:76-81.
39. Im JA, Kim SH, Lee JW, et al. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults. Metabolism 2006;55:1546-50.
40. von Eynatten M, Schneider JG, Humpert PM, et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care 2004;27:2925-9.